Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-07

FDA Approved: OXAYDO — Supplemental Application (Zyla Life Sciences US LLC)

View source ↗

Summary

FDA approves a supplemental application for Oxaydo (oxycodone hydrochloride) by Zyla Life Sciences US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXAYDO (Oxycodone hydrochloride)

Snippet

SUPPL AP for OXAYDO (OXYCODONE HYDROCHLORIDE)